BeOne Medicines Ltd (HK:6160)
:6160
Want to see HK:6160 full AI Analyst Report?
Comparison Results
BeOne Medicines Ltd
HK$193.20
HK$273.94B
34.81
28.13%
14 Buy
0 Hold
0 Sell
Strong Buy
Innovent Biologics
HK$91.50
HK$143.49B
145.72
43.91%
14 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$35.72
HK$135.98B
24.33
36.05%
11 Buy
1 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$122.90
HK$355.88B
16.25
93.74%
8 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$39.76
HK$206.79B
34.88
31.21%
10 Buy
0 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$63.35
HK$392.10B
48.50
11.24%
3 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:6160
BeOne Medicines Ltd
184.50
41.10
28.66%
HK:1801
Innovent Biologics
80.95
24.40
43.15%
HK:2269
Wuxi Biologics (Cayman)
32.72
9.62
41.65%
HK:2359
WuXi AppTec Co., Ltd. Class H
130.00
65.42
101.31%
HK:3692
Hansoh Pharmaceutical Group Company Limited
33.72
8.40
33.18%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
61.35
7.84
14.65%